查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1863134

全球血壓監測設備市場：洞察、競爭格局及市場預測（至2032年）

Blood Pressure Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

血壓監測設備市場摘要

  • 全球血壓監測設備市場預計將從 2024 年的 28.4232 億美元成長到 2032 年的 60.865 億美元，反映出強勁且持續的成長。
  • 全球血壓監測設備市場在 2025 年至 2032 年的預測期內將以 10.01% 的複合年成長率成長。
  • 血壓監測設備市場的主要促進因素是高血壓和心血管疾病的盛行率不斷上升、居家醫療和遠端患者監護的日益普及、設備技術的不斷進步以及參與企業產品開發活動的增加。
  • 在血壓監測設備市場營運的主要企業包括：英國皇家飛利浦公司、通用電氣公司、A&D公司、Hill-Rom Services Inc.、美國診斷公司、Withings、Spacelabs Healthcare、Braun Healthcare、GF HEALTH PRODUCTS INC、Microlife Corporation、Rossmax International Ltd、歐姆龍醫療保健公司、S.ILL SA和Caretaker LLC。
  • 由於高血壓和心血管疾病的高發生率、先進的數位和穿戴式監測技術的廣泛應用，以及主要市場參與企業在該地區的存在，預計北美將主導血壓監測設備市場。此外，不斷成長的醫療保健支出、完善的醫療保健基礎設施以及人們對預防保健和家庭監測意識的提高，進一步鞏固了北美的市場領先地位。
  • 在血壓監測設備市場中，預計到 2024 年，數位/自動血壓計中的上臂式血壓計將佔主導地位。

血壓監測設備市場成長要素

  • 高血壓和心血管疾病盛行率的上升推動了血壓監測設備的需求激增：高血壓和心血管疾病盛行率的上升顯著增加了對血壓監測設備的需求，因為定期監測對於早期發現、有效管理和預防心臟病發作和中風等併發症至關重要。日益加重的疾病負擔促使醫療服務提供者和患者都開始採用先進的監測解決方案，包括家用和穿戴式裝置。
  • 居家醫療和遠端患者監護的日益普及推動血壓監測設備市場成長：隨著病患尋求在臨床環境之外獲得便利、經濟且持續的血壓監測解決方案，居家醫療和遠端患者監護普及正在推動血壓監測設備市場的成長。此外，能夠與醫療服務提供者即時共用數據的數位化互聯設備的興起也進一步促進了這一趨勢。
  • 血壓監測設備技術的不斷進步：血壓監測設備的技術不斷進步，包括數位式、穿戴式和人工智慧整合式監測儀的開發，正在提高其準確性、易用性和連接性。這些創新透過實現即時追蹤、遠端監測以及與醫療保健系統的無縫資料整合，推動了血壓監測設備的普及應用。

血壓監測設備市場報告區隔

本研究報告全面概​​述了全球血壓監測設備市場，重點分析了關鍵趨勢、成長促進因素、課題和機會。報告按產品、最終用戶和地區進行了詳細的市場區隔，並深入剖析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。報告詳細介紹了行業領導者的概況和最新的產品創新，為企業提供了識別市場潛力、制定策略規劃以及把握快速成長的血壓監測設備市場新機會所需的重要數據。

血壓監測儀是醫療設備，通常由袖帶、感測器和顯示器組成。它有助於診斷和管理高血壓及相關心血管疾病，並有手動、數位和穿戴式等多種形式，可用於臨床和家庭使用。

高血壓和心血管疾病盛行率的上升，以及居家醫療和遠端患者監護的日益普及，顯著推動了血壓監測設備的需求。同時，數位和穿戴式監測儀等技術的不斷進步，以及主要企業活性化產品研發力度，使得血壓監測設備更加精準、易用且普及。這些因素正在加速血壓監測設備的普及，並推動整個市場的成長。

血壓監測設備市場的最新動態和趨勢是什麼？

由於高血壓和心血管疾病的增加，血壓監測設備市場目前正經歷快速成長。

根據DelveInsight的預測（2024年），全球30至79歲的成年人中將有約12.9億人患有高血壓。高血壓是世界上最常見的慢性疾病之一，需要定期監測才能有效控制，這使其成為推動血壓監測設備市場整體成長的主要因素。由於數百萬人面臨中風、心臟病發作和腎衰竭等嚴重併發症的風險，持續血壓監測的需求正在迅速成長。不斷成長的患者群體正在推動家用數位血壓計、穿戴式裝置和先進的醫院血壓監測系統的普及，從而促進市場擴張。

此外，根據DelveInsight的預測（2024年），2023年七大經濟體將新增約2,600萬例動脈粥狀硬化性心血管疾病病例，預計到2034年這一數字還將進一步成長。心臟病患者需要頻繁且準確的監測，以控制風險並預防併發症。由於血壓控制不佳是心臟病發作、中風和心臟衰竭的主要原因，醫療保健機構重視在臨床環境和家庭環境中定期監測血壓，從而推動了血壓監測設備市場的整體成長。

此外，主要市場參與企業加強產品研發力度，進一步推動了血壓監測設備的整體市場成長。例如，歐姆龍醫療保健公司於2025年5月發布了一款內建人工智慧心房顫動檢測功能的家用血壓計。血壓計是醫療設備的首創，它搭載了歐姆龍公司最新的機器學習演算法IntelliSense™ AFib，可在每次測量血壓時自動檢測房顫，從而及早發現中風和心臟衰竭的高風險人群。

儘管血壓監測設備市場成長強勁，但仍面臨許多重大阻礙與課題。其中一個關鍵問題是許多設備（尤其是消費級產品）的準確性和可靠性參差不齊，這損害了患者和醫療專業人員的信任。另一個重大障礙是新設備監管和認證流程嚴格、耗時且成本高昂，導致產品上市延遲，阻礙創新。此外，經臨床驗證的先進檢驗價格昂貴，限制了其普及，尤其是在開發中國家和無健保患者群體中。最後，患者操作失誤仍然是一個重大課題，因為不正確的操作方法和缺乏使用者教育會導致讀數不準確，從而降低家庭監測在有效控制高血壓方面的價值。

血壓監測設備市場區隔分析

血壓監測設備市場按產品、最終用戶和地區分類

上臂式電子/自動血壓計市場佔主導地位

在血壓監測設備市場中，臂式數位/自動血壓計預計將佔主導地位，到 2024 年將佔市場佔有率的近 60%。這一領先地位將由幾個關鍵因素驅動。

上臂式血壓計被公認為家用血壓監測的黃金標準。由於其配戴位置更靠近心臟，上臂式血壓計比腕式或指式血壓計提供更穩定、更可靠的讀數，後者更容易受到位置變化的影響。這種更高的準確性對於有效的病患管理至關重要，也是醫療專業人員始終建議使用上臂式血壓計的主要原因。

此外，許多臂式血壓計都經過了美國心臟協會 (AHA) 和歐洲高血壓學會 (ESH) 等機構制定的臨床檢驗通訊協定的檢驗。這種檢驗不僅增強了消費者的信任，也鞏固了它們作為臨床醫生和消費者首選產品的地位。

此外，上臂式血壓計正日益整合到遠端醫療和遠端患者監護（RPM）平台中，從而實現與醫療服務提供者之間的無縫資料共用。其久經考驗的可靠性確保醫生能夠獲得準確、可操作的數據，以指南治療決策，使這些設備成為現代高血壓管理的重要組成部分。

按最終用戶分類：醫院佔市場主導地位

目前，醫院產業在血壓監測設備市場佔主導地位，預計到2024年將佔超過59%的市場。這一主導地位源自於醫院龐大的病患數量、重症加護環境下對持續、高精度監測的需求，以及醫院在昂貴的臨床級設備上的巨額投入。然而，居家醫療領域正經歷著最快的成長。這一趨勢的促進因素包括高血壓等慢性疾病在全球範圍內的日益普遍、遠距遠端醫療和遠端患者監護（RPM）平台的日益普及，以及以患者為中心的居家醫療的重大轉變。老年人口的成長也推動了這一成長，因為家庭監測為長期健康管理提供了一種便利且經濟高效的解決方案。

血壓監測設備市場區域分析

北美血壓監測設備市場趨勢

參與企業。此外，醫療保健支出的成長、完善的醫療基礎設施以及人們對預防保健和家庭監測意識的提高，進一步鞏固了北美的市場領先地位。

DelveInsight 估計（2024 年），到 2023 年，美國將有約 1,400 萬名男性和約 11,000 名女性患有動脈粥狀硬化性心血管疾病。

此外，分析師預測（2024年），美國超過一半的成年人將患有高血壓（48.2%，即1.199億人）。美國粥狀硬化性心血管疾病的高發生率以及高血壓患者人數眾多，顯著擴大了血壓監測設備的市場。由於數百萬患者面臨嚴重併發症的風險，因此在診所和家中定期、準確地監測血壓的需求日益成長。這種需求正在推動先進的、數位連接的血壓監測設備的廣泛應用，這些設備支援早期發現、持續管理和改善患者預後。

此外，全部區域不斷增加的產品研發活動也進一步推動了血壓監測設備的整體市場成長。例如，2024年2月，Joytech Healthcare的全自動臂式電子血壓計獲得了FDA 510(k)認證。

因此，上述因素預計將推動北美血壓監測設備市場的成長。

歐洲血壓監測設備市場趨勢

歐洲血壓監測設備市場的特點是注重品質、人口快速老化以及對綜合數位健康解決方案的追求，這使得該地區成為傳統和智慧監測技術的關鍵市場。

歐洲市場的主要趨勢

1. 人口老化與慢性病管理：歐洲正經歷快速的人口老化，65歲以上人口年齡層高。隨著老齡化的成長，高血壓和其他心血管疾病的盛行率也隨之增加，因此，這種人口結構變化是市場的主要促進因素。這一趨勢推動了對可靠且易於使用的血壓監測儀的需求，以便在家中進行長期慢性病管理。

2. 數位/自動血壓計的主導地位：雖然傳統血壓計仍在繼續使用，但市場主要由數位/自動血壓計，尤其是上臂式血壓計。這些設備因其臨床準確性和易用性而廣受歡迎，這對患者和醫護人員來說都是重要的考量。英國和德國是關鍵市場，這兩個國家對高品質、精密設計的血壓計需求旺盛。

3.居家醫療領域的成長：歐洲在居家醫療轉型方面處於領先地位。 「居家醫院」計畫以及政府對遠端醫療和數位健康的扶持，正在加速遠端血壓監測儀等設備的應用。這一趨勢的推動力源於對經濟高效的醫療保健服務的需求，以及患者越來越偏好在家中舒適地管理自身健康狀況。

4. 智慧型裝置和遠端醫療的興起：具備藍牙連接和應用程式整合功能的「智慧型」血壓計儀是成長最快的類別。這反映出市場對能夠與智慧型手機、平板電腦和遠端醫療平台無縫共用數據的設備的需求日益成長，使醫生能夠遠端追蹤患者數據，並提供更及時、更個人化的醫療服務。

5. 監管環境（歐盟醫療器材法規）：歐洲市場深受歐盟醫療設備法規 (EU MDR) 的影響。雖然這給一些製造商在合規和認證方面帶來了課題，但也確保了上市醫療器材的高安全性和高性能標準。這種嚴格的監管有助於建立信任，並鞏固歐洲在高品質醫療設備領域的聲譽。

亞太地區血壓監測設備市場趨勢

亞太地區血壓監測設備市場正經歷顯著成長，這得益於人口結構變化、技術普及和醫療保健模式演變的獨特組合，使該地區有望在未來幾年成為全球成長最快的市場之一。

亞太市場的主要趨勢

  • 老年人口的爆炸性成長：亞太地區擁有世界上一些老化速度最快的地區（例如日本、中國和韓國），是市場擴張的主要動力。高血壓是該地區老年人口的主要健康問題，龐大的老年人口群體對臨床和家用血壓監測解決方案的需求也隨之激增。
  • 高血壓和文明病盛行率上升：在中國和印度等國家，都市化和生活方式的改變導致高血壓、肥胖和糖尿病等慢性疾病激增。日益加重的疾病負擔，以及人們對定期監測血壓必要性的認知不斷提高，正在推動血壓計的廣泛應用。
  • 轉向居家醫療和自我監測：醫療保健正呈現出從醫院轉移到家庭的明顯趨勢，這主要受對成本效益和患者便利性的需求所驅動。因此，居家醫療產業蓬勃發展，越來越多的消費者購買用於自我監測的數位化和自動化設備。
  • 技術融合：亞太市場是技術創新的溫床。
  • 數位和智慧型裝置：數位血壓計越來越受歡迎，像歐姆龍（日本一家主要企業）這樣的公司正在連網設備領域處於主導。
  • 穿戴式科技：雖然目前仍是一個小眾市場，但對智慧型手錶和其他可追蹤血壓的穿戴裝置的需求正在成長，尤其是在更年輕、更懂科技、更注重健康的人群中。
  • 遠端醫療和人工智慧：政府措施和私人公司正在加速將血壓監測儀整合到遠端醫療平台和人工智慧驅動的數據分析中，從而實現遠端患者監測，改善患者治療效果和治療依從性，尤其是在農村人口眾多且分散的國家。
  • 政府措施與醫療保健支出成長：該地區許多國家的政府都在積極投資醫療保健基礎設施，並實施公共衛生計畫以應對慢性疾病，包括向高風險族群分發血壓監測儀和進行公眾意識提升宣傳活動。這種自上而下的支持，加上可支配收入的成長，正在擴大監測設備的普及率和需求。

血壓監測設備市場的主要企業

以下列出了血壓監測設備市場的主要企業，它們總合佔最大的市場佔有率，並引領著行業趨勢：

  • Koninklijke Philips NV
  • General Electric Company
  • A&D Company
  • Hill-Rom Services Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF HEALTH PRODUCTS INC
  • Microlife Corporation
  • Rossmax International Ltd.
  • OMRON Healthcare Inc.
  • SCHILLER AG
  • Contec, Spengler
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Biobeat
  • Aktiia SA
  • Caretaker LLC
  • 其他

血壓監測設備市場集中度適中，少數幾家佔主導地位的公司與數量迅速成長的小型創新企業之間形成了明顯的競爭格局。歐姆龍、A&D Medical 和飛利浦等傳統醫療設備巨頭憑藉其成熟的品牌、廣泛的分銷網路以及對經臨床檢驗的上臂式數位血壓計的專注，保持著強大的市場地位。這為新參與企業設定了很高的進入門檻。然而，技術創新的蓬勃發展使市場格局日益活躍。新興企業和專業公司正在無袖帶穿戴裝置和人工智慧遠端患者監護系統等新興領域展開激烈競爭。這些新參與企業不僅推出了新產品，還降低了價格，課題了現有企業的傳統經營模式。這種轉變迫使市場領導增加研發投入、尋求策略夥伴關係並收購這些小型創新企業，以保持競爭力並拓展其產品系列，進入快速成長的居家醫療和數位健康領域。

血壓監測設備市場最新發展動態

  • 2025年1月，FDA核准了Biobeat Technologies Ltd.的BB-613-BPM貼片。 BB-613-BPM貼片是一款穿戴式設備，利用脈搏波傳導時間（PWTT）追蹤血壓變化。本設備需使用FDA核准的示波式血壓計進行校準，並提供24小時監測，使用者可每15分鐘進行一次測量。收集到的數據可透過Biobeat平台提供給醫療專業人員。
  • 2024年9月，Carematix推出了首款專為臨床試驗設計的連網盲法血壓計和體重計。該系統在確保數據完整性的同時，維持了受試者和臨床實驗的盲法，從而提高了研究的準確性，並能夠在不影響研究通訊協定的前提下及時進行干預。
  • 2024 年 2 月，Joytec Healthcare 的全自動臂式數位血壓監測儀獲得了 FDA 510(k) 許可。
  • 2024 年 1 月，Nanowear 的 SimpleSense-BP 獲得了 FDA 510(k) 許可，這是一款由人工智慧驅動的連續無袖帶血壓計，專為高血壓診斷管理而設計。

血壓監測設備市場區隔

  • 血壓監測設備產品的暴露
  • 數位/自動血壓計
  • 穿戴式血壓計
  • 上臂血壓計
  • 腕式血壓計
  • 指式血壓計
  • 手動血壓計
  • 水銀血壓計
  • 表式血壓計
  • 血壓監測設備最終用戶暴露
  • 醫院
  • 門診手術中心
  • 居家醫療
  • 其他
  • 各地區血壓監測設備使用量
  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太其他地區
  • 世界其他地區
  • 南美洲
  • 中東
  • 非洲

影響分析

人工智慧驅動的創新與應用：

人工智慧 (AI) 驅動的創新正在革新血壓監測設備，實現更精準、個人化和持續的健康評估。 AI 演算法分析複雜的生理訊號，包括脈搏波形、光電容積脈搏波描記法 (PPG) 和心電圖 (ECG)，無需依賴傳統袖帶即可估算血壓。這些技術能夠進行預測分析、早期發現高血壓，並對異常值發出即時警報，使患者和醫療服務提供者都能及時採取干涉措施。此外，AI 與穿戴式裝置和遠端醫療平台的整合，促進了遠端監測、數據主導的洞察分析和個人化治療方案的製定，從而將血壓管理從被動應對轉變為主動、持續的健康管理。

美國關稅對血壓監測設備市場的影響分析

美國對進口商品加徵的新關稅為全球血壓監測設備市場帶來了重大而複雜的課題。這些關稅提高了關鍵電子元件的成本，直接增加了製造商的生產成本。這迫使企業要么自行承擔這些成本，降低利潤率，要么將其轉嫁給消費者和醫療服務提供者，從而可能導致家用和臨床設備的價格上漲。為了應對這項課題，企業正在策略性地重新評估並多元化其全球供應鏈，以減少對高稅收國家的依賴。雖然這可能會促進一些國內生產，但這在成本和物流方面都是一項極具課題性的任務，對中小企業的影響尤其嚴重。關稅的影響在佔市場主導地位的數位/自動化領域將最為顯著，而這些設備價格的下降可能會阻礙遠端患者監護計畫的發展。

這項分析對客戶有何幫助？

  • 成本管理：了解關稅環境可以讓客戶預測成本上漲，並據此調整定價策略，確保盈利。
  • 供應鏈最佳化：可以確定替代採購方案，實現供應鏈多元化，以減少對高關稅地區的依賴，並提高韌性。
  • 監管導航：在不斷變化的法規環境中，專家指導可協助您保持合規並避免潛在的法律課題。
  • 策略規劃洞察關稅的影響使客戶能夠就製造地、夥伴關係和打入市場策略做出明智的決策。

目錄

第1章 血壓監測設備市場報告概述

2. 血壓監測設備市場摘要整理

  • 市場概覽

第3章：血壓監測設備市場關鍵因素分析

  • 血壓監測設備市場促進因素
    • 高血壓和心血管疾病盛行率不斷上升
    • 家庭醫療保健和遠端醫療監測的普及程度日益提高
    • 血壓監測設備的技術不斷進步
    • 主要市場參與者加大產品研發力度
  • 血壓監測設備市場的阻礙與課題
    • 對設備準確性和可靠性的擔憂
    • 嚴格的規章制度和認證流程
  • 血壓監測設備市場機遇
    • 人工智慧技術的應用日益廣泛

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：血壓監測設備市場：波特五力分析

第7章 血壓監測設備市場評估

  • 依產品
  • 最終用戶
  • 按地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

10. 血壓監測設備市場中的公司與產品概況

  • Koninklijke Philips NV
  • General Electric Company
  • A&D Company
  • Hill-Rom Services Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF HEALTH PRODUCTS INC
  • Microlife Corporation
  • Rossmax International Ltd.
  • OMRON Healthcare Inc.
  • SCHILLER AG
  • Contec
  • Spengler
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Biobeat
  • Aktiia SA, Caretaker LLC
  • Caretaker LLC

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0012

Blood Pressure Monitoring Devices Market Summary

  • The global blood pressure monitoring devices market is expected to increase from USD 2,842.32 million in 2024 to USD 6,086.50 million by 2032, reflecting strong and sustained growth.
  • The global blood pressure monitoring devices market is growing at a CAGR of 10.01% during the forecast period from 2025 to 2032.
  • The market of blood pressure monitoring devices is being primarily driven by the rising prevalence of hypertension and cardiovascular diseases, increasing shift towards home healthcare & remote patient monitoring, increasing technological advancements in devices, and an increase in product development activities among the key market players.
  • The leading companies operating in the blood pressure monitoring devices market include Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, Rossmax International Ltd, OMRON Healthcare Inc, SCHILLER AG, Contec, Spengler, ICU Medical Inc, B. Braun Melsungen AG, Biobeat, Aktiia SA, Caretaker LLC, and others.
  • North America is expected to dominate the overall blood pressure monitoring devices market due to the high prevalence of hypertension and cardiovascular diseases, strong adoption of advanced digital and wearable monitoring technologies, and the presence of leading market players in the region. Additionally, rising healthcare expenditure, well-established healthcare infrastructure, and increasing awareness about preventive care and home-based monitoring further strengthen North America's market leadership.
  • In the blood pressure monitoring devices market, the upper arm-based segment within digital/automated blood pressure monitors is projected to dominate in 2024.

Factors Contributing to the Growth of the Blood Pressure Monitoring Devices Market

  • Rising prevalence of hypertension and cardiovascular diseases leading to a surge in blood pressure monitoring devices: The rising prevalence of hypertension and cardiovascular diseases is driving significant demand for blood pressure monitoring devices, as regular monitoring is essential for early detection, effective management, and prevention of complications such as heart attack and stroke. This growing disease burden is pushing both healthcare providers and patients to adopt advanced monitoring solutions, including home-use and wearable devices.
  • Increasing shift towards home healthcare & remote patient monitoring escalating the market of blood pressure monitoring devices: The increasing shift towards home healthcare and remote patient monitoring is boosting the market for blood pressure monitoring devices, as patients seek convenient, cost-effective, and continuous monitoring solutions outside clinical settings. This trend is further supported by the rise of digital and connected devices that enable real-time data sharing with healthcare providers.
  • Increasing technological advancements in blood pressure monitoring devices: Increasing technological advancements in blood pressure monitoring devices, such as the development of digital, wearable, and AI-integrated monitors, are enhancing accuracy, ease of use, and connectivity. These innovations are driving higher adoption by enabling real-time tracking, remote monitoring, and seamless data integration with healthcare systems.

Blood Pressure Monitoring Devices Market Report Segmentation

This Blood Pressure Monitoring Devices market report offers a comprehensive overview of the global blood pressure monitoring devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product (Digital/Automated Blood Pressure Monitors {Wearable Blood Pressure Monitors, Upper Arm-based Blood Pressure Monitors, Wrist-based Blood Pressure Monitors, and Finger-based Blood Pressure Monitors} and Manual Blood Pressure Monitors {Mercury Blood Pressure Monitors and Aneroid Blood Pressure Monitors}), End-User (Hospitals, Ambulatory Surgical Centers, Home-Care Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing blood pressure monitoring devices market.

A blood pressure monitoring device is a medical instrument used to measure and track a person's blood pressure levels, typically consisting of a cuff, sensor, and display. It helps in diagnosing and managing hypertension and related cardiovascular conditions, available in manual, digital, and wearable forms for clinical and home use.

The rising prevalence of hypertension and cardiovascular diseases, coupled with the growing shift towards home healthcare and remote patient monitoring, is significantly driving demand for blood pressure monitoring devices. Alongside this, continuous technological advancements, such as digital and wearable monitors, and increased product development activities by key players are making devices more accurate, user-friendly, and accessible. Collectively, these factors are accelerating adoption and boosting the overall market growth.

What are the latest Blood Pressure Monitoring Devices Market Dynamics and Trends?

The market for blood pressure monitoring devices is gaining pace at present, owing to the rising cases of hypertension and cardiovascular diseases.

According to DelveInsight's estimates (2024), an estimated 1.29 billion adults aged 30-79 years worldwide had hypertension. Hypertension is a major factor boosting the overall market for blood pressure monitoring devices, as it is one of the most common chronic conditions worldwide and requires regular monitoring for effective management. With millions of people at risk of serious complications like stroke, heart attack, and kidney failure, the need for continuous blood pressure tracking is rising rapidly. This growing patient pool is driving higher adoption of home-use digital monitors, wearable devices, and advanced hospital-based systems, thereby fueling market expansion.

Additionally, as per our DelveInsight estimates (2024), in 2023, 7MM accounted for nearly 26 million cases of atherosclerotic cardiovascular disease, which was further expected to increase by 2034. Patients with heart-related conditions require frequent and accurate monitoring to manage risks and prevent complications. Since uncontrolled blood pressure is a leading cause of heart attacks, strokes, and heart failure, healthcare providers emphasize regular tracking, both in clinical settings and at home, thereby boosting the overall market of blood pressure monitoring devices.

Moreover, the increase in product development activities among the key market players is further boosting the overall market of blood pressure monitoring devices. For instance, in May 2025, OMRON Healthcare introduced home blood pressure monitors with built-in AI-powered detection of atrial fibrillation. In a medical device first, OMRON blood pressure monitors, which feature the company's new novel machine learning IntelliSense(TM) AFib algorithm, will automatically check for AFib during every blood pressure measurement and can provide early detection for a high stroke and heart failure risk.

The blood pressure monitoring devices market faces several significant restraints and challenges despite its robust growth. A primary concern is the inconsistent accuracy and reliability of many devices, especially consumer-grade models, which erodes trust among both patients and healthcare professionals. The stringent regulatory and certification processes for new devices are also a major hurdle, as they can be both time-consuming and costly, thereby delaying product launches and hindering innovation. Furthermore, the high cost of clinically validated and advanced monitors limits their accessibility, particularly in developing economies or for uninsured patients. Lastly, patient user error remains a significant challenge, as improper technique and a lack of user education can lead to inaccurate readings, compromising the value of home monitoring for effective hypertension management.

Blood Pressure Monitoring Devices Market Segment Analysis

Blood Pressure Monitoring Devices Market by Product (Digital/Automated Blood Pressure Monitors {Wearable Blood Pressure Monitors, Upper Arm-based Blood Pressure Monitors, Wrist-based Blood Pressure Monitors, and Finger-based Blood Pressure Monitors} and Manual Blood Pressure Monitors {Mercury Blood Pressure Monitors and Aneroid Blood Pressure Monitors}), End-User (Hospitals, Ambulatory Surgical Centers, Home-Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product: Upper Arm-based Digital/Automated Blood Pressure Monitor Category Dominates the Market

In the blood pressure monitoring devices market, the upper arm-based segment within digital/automated blood pressure monitors is projected to dominate in 2024, accounting for nearly 60% of the market share. This leadership is driven by several key factors.

Upper arm monitors are widely regarded as the gold standard for at-home blood pressure measurement. Positioned closer to the heart, they provide more consistent and reliable readings than wrist or finger monitors, which are often influenced by body position. This higher level of accuracy is critical for effective patient management and is a major reason why healthcare professionals consistently recommend them.

Furthermore, many upper arm monitors have undergone clinical validation against protocols established by organizations such as the American Heart Association (AHA) and the European Society of Hypertension (ESH). This validation not only builds trust but also solidifies their position as the preferred choice for both clinicians and consumers.

In addition, upper arm monitors are increasingly being integrated into telehealth and remote patient monitoring (RPM) platforms, enabling seamless data sharing with healthcare providers. Their proven reliability ensures that physicians receive accurate, actionable data to guide treatment decisions, making these devices a cornerstone of modern hypertension management.

By End-User: Hospitals Dominate the Market

In the blood pressure monitoring devices market, the Hospitals segment currently holds the dominant position, with a market share of over 59% in 2024. This dominance is attributed to the high volume of patients they serve, the need for continuous and highly accurate monitoring in critical care settings, and their substantial spending on expensive, clinical-grade devices. However, the Home Healthcare segment is experiencing the most rapid growth. This trend is fueled by the rising global prevalence of chronic diseases like hypertension, the growing acceptance of telehealth and remote patient monitoring (RPM) platforms, and a major shift towards patient-centric, at-home care. The increasing geriatric population also drives this growth, as home-based monitoring provides a convenient and cost-effective solution for long-term health management.

Blood Pressure Monitoring Devices Market Regional Analysis

North America Blood Pressure Monitoring Devices Market Trends

North America is projected to dominate the global blood pressure monitoring devices market in 2024, accounting for approximately 35% of the total share, driven by the high prevalence of hypertension and cardiovascular diseases, strong adoption of advanced digital and wearable monitoring technologies, and the presence of leading market players in the region. Additionally, rising healthcare expenditure, well-established healthcare infrastructure, and increasing awareness about preventive care and home-based monitoring further strengthen North America's market leadership.

According to the DelveInsight estimates (2024), in the United States, in 2023, ~14 million males and ~11 thousand females were affected with Atherosclerotic Cardiovascular Disease.

Additionally, as per our analyst estimates (2024), more than half of adults had high blood pressure (48.2%, 119.9 million) in the United States. The high burden of atherosclerotic cardiovascular disease and the large population affected by hypertension in the United States are significantly boosting the market for blood pressure monitoring devices. With millions of patients at risk of severe complications, there is a growing need for regular and accurate blood pressure monitoring in both clinical and home settings. This demand is driving wider adoption of advanced, digital, and connected devices to support early detection, ongoing management, and better patient outcomes.

Furthermore, the increase in product development activities across the region is further boosting the overall market of blood pressure monitoring devices. For instance, in February 2024, Joytech Healthcare secured FDA 510(k) clearance for its fully automatic, arm-type digital blood pressure monitor.

Therefore, the factors mentioned above are expected to drive the growth of the blood pressure monitoring devices market in North America.

Europe Blood Pressure Monitoring Devices Market Trends

The European blood pressure monitoring devices market is characterized by a strong emphasis on quality, a rapidly aging population, and a push towards integrated digital health solutions. The region is a key market for both traditional and smart monitoring technologies.

Key Trends in the European Market

1. Aging Population and Chronic Disease Management: Europe has a rapidly aging population, with a significant portion of its citizens aged 65 and older. This demographic shift is the primary driver for the market, as the prevalence of hypertension and other cardiovascular diseases increases with age. This trend is fueling demand for reliable, easy-to-use blood pressure monitors for long-term chronic disease management in the home.

2. Dominance of Digital/Automated Monitors: While traditional devices are still in use, the market is overwhelmingly dominated by digital/automated blood pressure monitors, especially the upper-arm-based models. These devices are highly popular due to their clinical accuracy and ease of use, which are critical factors for both patients and healthcare professionals. The UK and Germany, in particular, are leading markets, with a high demand for high-quality, precision-engineered products.

3. Growth of the Home Healthcare Segment: Europe is at the forefront of the shift towards home-based care. "Hospital-at-Home" initiatives and government support for telemedicine and digital health are accelerating the adoption of blood pressure monitors for remote patient monitoring. This trend is driven by the need for cost-effective healthcare delivery and a growing patient preference for managing their conditions from the comfort of their homes.

4. Increasing Adoption of Smart Devices and Telehealth: The "smart" blood pressure monitor segment, which includes devices with Bluetooth connectivity and app integration, is the fastest-growing category. This reflects a growing demand for devices that can seamlessly share data with smartphones, tablets, and telehealth platforms, enabling doctors to remotely track patient data and provide more timely and personalized care.

5. Regulatory Landscape (EU MDR): The European market is heavily influenced by the Medical Devices Regulation (EU MDR). While this has created challenges for some manufacturers in terms of compliance and certification, it also ensures a high standard of safety and performance for devices entering the market. This regulatory rigor builds trust and reinforces Europe's reputation for high-quality medical devices.

Asia-Pacific Blood Pressure Monitoring Devices Market Trends

The Asia-Pacific blood pressure monitoring devices market is experiencing significant growth, driven by a unique blend of demographic shifts, technological adoption, and evolving healthcare models. The region is poised to be one of the fastest-growing markets globally in the coming years.

Key Trends in the Asia-Pacific Market

  • Explosive Growth in the Geriatric Population: The Asia-Pacific region, home to some of the world's most rapidly aging societies (e.g., Japan, China, and South Korea), is a major catalyst for market expansion. Hypertension is a key health concern in this demographic, and the sheer volume of older individuals is creating a massive demand for both clinical and home-based blood pressure monitoring solutions.
  • Rising Prevalence of Hypertension and Lifestyle Diseases: Urbanization and changing lifestyles in countries like China and India have led to a surge in chronic diseases, including hypertension, obesity, and diabetes. This increasing disease burden, coupled with a growing awareness of the need for regular monitoring, is fuelling the adoption of blood pressure monitors.
  • Shift to Home Healthcare and Self-Monitoring: There is a clear trend towards decentralizing healthcare from hospitals to homes. This is driven by the desire for cost-effective care and patient convenience. As a result, the home healthcare segment is growing rapidly, with consumers increasingly purchasing digital and automated devices for self-monitoring.
  • Technological Integration: The Asia-Pacific market is a hotbed for technological innovation.
  • Digital and Smart Devices: The adoption of digital blood pressure monitors is widespread, with companies like OMRON (a major domestic player in Japan) leading the charge with connected devices.
  • Wearable Tech: While still a smaller segment, there is a rising demand for smartwatches and other wearables that can track blood pressure, particularly among the tech-savvy younger population and those with a focus on wellness.
  • Telehealth and AI: Government initiatives and private companies are increasingly integrating blood pressure monitors with telehealth platforms and AI-powered data analytics. This allows for remote patient monitoring, especially in countries with vast and dispersed rural populations, improving patient outcomes and treatment adherence.
  • Government Initiatives and Increased Healthcare Spending: Many governments in the region are actively investing in healthcare infrastructure and implementing public health programs to combat chronic diseases. For example, some programs involve distributing blood pressure monitors to at-risk populations and promoting public awareness campaigns. This top-down support, combined with rising disposable incomes, is expanding access to and demand for monitoring devices.

Who are the major players in the blood pressure monitoring devices market?

The following are the leading companies in the blood pressure monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Koninklijke Philips N.V.
  • General Electric Company
  • A&D Company
  • Hill-Rom Services Inc.
  • American Diagnostic Corporation
  • Withings
  • Spacelabs Healthcare
  • Braun Healthcare
  • GF HEALTH PRODUCTS INC
  • Microlife Corporation
  • Rossmax International Ltd.
  • OMRON Healthcare Inc.
  • SCHILLER AG
  • Contec, Spengler
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Biobeat
  • Aktiia SA
  • Caretaker LLC
  • Others

How is the competitive landscape shaping the blood pressure monitoring devices market?

The blood pressure monitoring devices market is moderately concentrated, with a clear competitive divide between a few dominant players and a rapidly growing segment of smaller, innovative companies. Traditional medical device giants like OMRON, A&D Medical, and Philips maintain a strong hold on the market due to their established brand reputation, extensive distribution networks, and a focus on clinically validated, upper-arm digital monitors. This creates a high barrier to entry for newcomers. However, the landscape is becoming increasingly dynamic due to the surge of technological innovation. Startups and specialized firms are aggressively competing in emerging categories, such as cuffless wearables and AI-powered remote patient monitoring systems. These new players are not only introducing novel products but are also driving down prices and challenging the traditional business models of established companies. This shift has forced market leaders to invest heavily in R&D, pursue strategic partnerships, and acquire these smaller innovators to stay competitive and expand their product portfolios into the fast-growing home healthcare and digital health segments.

Recent Developmental Activities in the Blood Pressure Monitoring Devices Market

  • In January 2025, the FDA cleared Biobeat Technologies Ltd.'s BB-613-BPM Patch, a wearable device that tracks blood pressure changes using Pulse Wave Transit Time (PWTT). This device requires calibration with an FDA-cleared oscillometric monitor and provides 24-hour monitoring with user-initiated measurements every 15 minutes. Data collected can be accessed via the Biobeat platform for healthcare professionals to review.
  • In September 2024, Carematix launched the first connected blinded blood pressure monitor and scale designed for clinical trials. This system ensures data integrity while maintaining participant and investigator blinding, supporting trial accuracy, and enabling timely interventions without compromising study protocols.
  • In February 2024, Joytech Healthcare secured FDA 510(k) clearance for its fully automatic, arm-type digital blood pressure monitor.
  • In January 2024, Nanowear received FDA 510(k) clearance for its SimpleSense-BP-an AI-enabled, continuous, cuffless blood pressure monitor designed for hypertension diagnostic management.

Blood Pressure Monitoring Devices Market Segmentation

  • Blood Pressure Monitoring Devices Product Exposure
  • Digital/Automated Blood Pressure Monitors
  • Wearable Blood Pressure Monitors
  • Upper Arm-based Blood Pressure Monitors
  • Wrist-based Blood Pressure Monitors
  • Finger-based Blood Pressure Monitors
  • Manual Blood Pressure Monitors
  • Mercury Blood Pressure Monitors
  • Aneroid Blood Pressure Monitors
  • Blood Pressure Monitoring Devices End-Users Exposure
  • Hospitals
  • Ambulatory Surgical Centers
  • Home-Care Settings
  • Others
  • Blood Pressure Monitoring Devices Geography Exposure
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • South America
  • Middle East
  • Africa

Impact Analysis

AI-Powered Innovations and Applications:

Artificial intelligence (AI)-powered innovations are revolutionizing blood pressure monitoring devices by enabling more accurate, personalized, and continuous health assessments. AI algorithms analyze complex physiological signals, such as pulse waveforms, photoplethysmography (PPG), and electrocardiography (ECG), to estimate blood pressure without relying solely on traditional cuffs. These technologies allow for predictive analytics, early detection of hypertension, and real-time alerts for abnormal readings, empowering both patients and healthcare providers to make timely interventions. Additionally, AI integration with wearable devices and telemedicine platforms facilitates remote monitoring, data-driven insights, and personalized treatment plans, transforming blood pressure management from reactive care to proactive, continuous health management.

U.S. Tariff Impact Analysis on Blood Pressure Monitoring Devices Market:

The new U.S. tariffs on imported goods are a significant and complex headwind for the global blood pressure monitoring devices market. By raising the cost of essential electronic components, these tariffs directly increase production expenses for manufacturers. This forces companies to either absorb the cost, which erodes profit margins, or pass it on to consumers and healthcare providers, potentially leading to higher prices for both home-use and clinical devices. In response to this, companies are strategically re-evaluating and diversifying their global supply chains to reduce reliance on heavily taxed countries. While this may incentivize some domestic production, it is a costly and logistically challenging endeavor that disproportionately affects smaller companies. The tariffs' impact is felt most acutely in the dominant digital/automated segment and could hinder the growth of remote patient monitoring programs by making these devices less affordable.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the blood pressure monitoring devices market report study

  • Market size analysis for the current blood pressure monitoring devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the blood pressure monitoring devices market.
  • Various opportunities available for the other competitors in the blood pressure monitoring devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current blood pressure monitoring devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the blood pressure monitoring devices market growth in the future?

Frequently Asked Questions for the Blood Pressure Monitoring Devices Market

1. What is the growth rate of the blood pressure monitoring devices market?

  • The blood pressure monitoring devices market is estimated to grow at a CAGR of 10.01% during the forecast period from 2025 to 2032.

2. What is the market for blood pressure monitoring devices?

  • The blood pressure monitoring devices market was valued at USD 2,842.32 million in 2024, and is expected to reach USD 6,086.50 million by 2032.

3. Which region has the highest share in the blood pressure monitoring devices market?

  • North America is expected to dominate the overall blood pressure monitoring devices market due to the high prevalence of hypertension and cardiovascular diseases, strong adoption of advanced digital and wearable monitoring technologies, and the presence of leading market players in the region. Additionally, rising healthcare expenditure, well-established healthcare infrastructure, and increasing awareness about preventive care and home-based monitoring further strengthen North America's market leadership.

4. What are the drivers for the blood pressure monitoring devices market?

  • The rising prevalence of hypertension and cardiovascular diseases, coupled with the growing shift towards home healthcare and remote patient monitoring, is significantly driving demand for blood pressure monitoring devices. Alongside this, continuous technological advancements, such as digital and wearable monitors, and increased product development activities by key players are making devices more accurate, user-friendly, and accessible. Collectively, these factors are accelerating adoption and boosting the overall market growth.

5. Who are the key players operating in the blood pressure monitoring devices market?

  • Some of the key market players operating in the blood pressure monitoring Devices market include Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, Rossmax International Ltd, OMRON Healthcare Inc., SCHILLER AG, Contec, Spengler, ICU Medical Inc., B. Braun Melsungen AG, Biobeat, Aktiia SA, Caretaker LLC, and others.

Table of Contents

1. Blood Pressure Monitoring Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Blood Pressure Monitoring Devices Market Executive Summary

  • 2.1 Market at Glance

3. Blood Pressure Monitoring Devices Market Key Factors Analysis

  • 3.1 Blood Pressure Monitoring Devices Market Drivers
    • 3.1.1 Rising prevalence of hypertension and cardiovascular diseases
    • 3.1.2 Increasing shift towards home healthcare & telehealth monitoring
    • 3.1.3 Increasing technological advancements in blood pressure monitoring devices
    • 3.1.4 Increase in product development activities among the key market players
  • 3.2 Blood Pressure Monitoring Devices Market Restraints and Challenges
    • 3.2.1 Concerns over Device Accuracy and Reliability
    • 3.2.2 Stringent Regulatory and Certification Process
  • 3.3 Blood Pressure Monitoring Devices Market Opportunity
    • 3.3.1 Increasing Adoption of Artificial Intelligence Technology

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Blood Pressure Monitoring Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Blood Pressure Monitoring Devices Market Assessment

  • 7.1 By Product
    • 7.1.1 Digital/Automated Blood Pressure Monitors
      • 7.1.1.1 Wearable Blood Pressure Monitors
      • 7.1.1.2 Upper Arm-based Blood Pressure Monitors
      • 7.1.1.3 Wrist-based Blood Pressure Monitors
      • 7.1.1.4 Finger-based Blood Pressure Monitors
    • 7.1.2 Manual Blood Pressure Monitors
      • 7.1.2.1 Mercury Blood Pressure Monitors
      • 7.1.2.2 Aneroid Blood Pressure Monitors
  • 7.2 By End-Users
    • 7.2.1 Hospitals
    • 7.2.2 Ambulatory Surgical Centers
    • 7.2.3 Home-Care Settings
    • 7.2.4 Others
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.1.2 Canada Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.1.3 Mexico Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.2 Europe
      • 7.3.2.1 France Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.2 Germany Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.3 United Kingdom Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.4 Italy Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.5 Spain Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.6 Rest of Europe Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.2 Japan Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.3 India Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.4 Australia Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.5 South Korea Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.6 Rest of Asia-Pacific Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1 Middle East Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.4.2 Africa Blood Pressure Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.4.3 South America Blood Pressure Monitoring Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Blood Pressure Monitoring Devices Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 General Electric Company
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 A&D Company
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Hill-Rom Services Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 American Diagnostic Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Withings
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Spacelabs Healthcare
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Braun Healthcare
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 GF HEALTH PRODUCTS INC
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Microlife Corporation
    • 10.10.1 Compan Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Rossmax International Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 OMRON Healthcare Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 SCHILLER AG
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Contec
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Spengler
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 ICU Medical Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 B. Braun Melsungen AG
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Biobeat
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Aktiia SA, Caretaker LLC
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Caretaker LLC
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Blood Pressure Monitoring Devices Market in Global (2022-2032)
  • Table 2: Blood Pressure Monitoring Devices Market in Global by Product (2022-2032)
  • Table 3: Blood Pressure Monitoring Devices Market in Global by End-User (2022-2032)
  • Table 4: Blood Pressure Monitoring Devices Market in Global by Geography (2022-2032)
  • Table 5: Blood Pressure Monitoring Devices Market in North America (2022-2032)
  • Table 6: Blood Pressure Monitoring Devices Market in the United States (2022-2032)
  • Table 7: Blood Pressure Monitoring Devices Market in Canada (2022-2032)
  • Table 8: Blood Pressure Monitoring Devices Market in Mexico (2022-2032)
  • Table 9: Blood Pressure Monitoring Devices Market in Europe (2022-2032)
  • Table 10: Blood Pressure Monitoring Devices Market in France (2022-2032)
  • Table 11: Blood Pressure Monitoring Devices Market in Germany (2022-2032)
  • Table 12: Blood Pressure Monitoring Devices Market in United Kingdom (2022-2032)
  • Table 13: Blood Pressure Monitoring Devices Market in Italy (2022-2032)
  • Table 14: Blood Pressure Monitoring Devices Market in Spain (2022-2032)
  • Table 15: Blood Pressure Monitoring Devices Market in the Rest of Europe (2022-2032)
  • Table 16: Blood Pressure Monitoring Devices Market in Asia-Pacific (2022-2032)
  • Table 17: Blood Pressure Monitoring Devices Market in China (2022-2032)
  • Table 18: Blood Pressure Monitoring Devices Market in Japan (2022-2032)
  • Table 19: Blood Pressure Monitoring Devices Market in India (2022-2032)
  • Table 20: Blood Pressure Monitoring Devices Market in Australia (2022-2032)
  • Table 21: Blood Pressure Monitoring Devices Market in South Korea (2022-2032)
  • Table 22: Blood Pressure Monitoring Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 23: Blood Pressure Monitoring Devices Market in the Rest of the World (2022-2032)
  • Table 24: Blood Pressure Monitoring Devices Market in the Middle East (2022-2032)
  • Table 25: Blood Pressure Monitoring Devices Market in Africa (2022-2032)
  • Table 26: Blood Pressure Monitoring Devices Market in South America (2022-2032)
  • Table 27: Competitive Landscape
  • Table 28: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Blood Pressure Monitoring Devices Market Drivers
  • Figure 2: Blood Pressure Monitoring Devices Market Restraints
  • Figure 3: Blood Pressure Monitoring Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in the Blood Pressure Monitoring Devices Market
  • Figure 5: US Tariff Impact on Blood Pressure Monitoring Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Blood Pressure Monitoring Devices Market in Global (2022-2032)
  • Figure 10: Blood Pressure Monitoring Devices Market in Global by Product (2022-2032)
  • Figure 11: Blood Pressure Monitoring Devices Market in Global by End-User (2022-2032)
  • Figure 12: Blood Pressure Monitoring Devices Market in Global by Geography (2022-2032)
  • Figure 13: Blood Pressure Monitoring Devices Market in North America (2022-2032)
  • Figure 14: Blood Pressure Monitoring Devices Market in the United States (2022-2032)
  • Figure 15: Blood Pressure Monitoring Devices Market in Canada (2022-2032)
  • Figure 16: Blood Pressure Monitoring Devices Market in Mexico (2022-2032)
  • Figure 17: Blood Pressure Monitoring Devices Market in Europe (2022-2032)
  • Figure 18: Blood Pressure Monitoring Devices Market in France (2022-2032)
  • Figure 19: Blood Pressure Monitoring Devices Market in Germany (2022-2032)
  • Figure 20: Blood Pressure Monitoring Devices Market in United Kingdom (2022-2032)
  • Figure 21: Blood Pressure Monitoring Devices Market in Italy (2022-2032)
  • Figure 22: Blood Pressure Monitoring Devices Market in Spain (2022-2032)
  • Figure 23: Blood Pressure Monitoring Devices Market in the Rest of Europe (2022-2032)
  • Figure 24: Blood Pressure Monitoring Devices Market in Asia-Pacific (2022-2032)
  • Figure 25: Blood Pressure Monitoring Devices Market in China (2022-2032)
  • Figure 26: Blood Pressure Monitoring Devices Market in Japan (2022-2032)
  • Figure 27: Blood Pressure Monitoring Devices Market in India (2022-2032)
  • Figure 28: Blood Pressure Monitoring Devices Market in Australia (2022-2032)
  • Figure 29: Blood Pressure Monitoring Devices Market in South Korea (2022-2032)
  • Figure 30: Blood Pressure Monitoring Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 31: Blood Pressure Monitoring Devices Market in the Rest of the World (2022-2032)
  • Figure 32: Blood Pressure Monitoring Devices Market in the Middle East (2022-2032)
  • Figure 33: Blood Pressure Monitoring Devices Market in Africa (2022-2032)
  • Figure 34: Blood Pressure Monitoring Devices Market in South America (2022-2032)
  • Figure 35: Competitive Landscape
  • Figure 36: Startup Funding & Investment Trends